Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

The effects of silencing of PI3K p85α on 5-FU-induced colorectal cancer cells apoptosis.

Sun Y, Tian H, Wang L, Yang H.

Med Oncol. 2013 Dec;30(4):704. doi: 10.1007/s12032-013-0704-7. Epub 2013 Aug 29.

PMID:
23990352
2.

[PI3K p85alpha gene silencing by RNA interference promotes 5-fluorouracil-induced apoptosis of colorectal cancer LoVo cells].

Yang H, Ni L, Ma YQ, Song YG.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):1085-8. Chinese.

3.

MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.

Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y, Mori M.

Ann Surg Oncol. 2012 Sep;19(9):3065-71. doi: 10.1245/s10434-012-2246-1. Epub 2012 Feb 10.

PMID:
22322955
4.

Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells.

Sun Y, Zhao S, Tian H, Xie X, Xiao F, Li K, Song Y.

Oncol Rep. 2009 Dec;22(6):1435-41.

PMID:
19885597
5.

Death associated protein 1 is correlated with the clinical outcome of patients with colorectal cancer and has a role in the regulation of cell death.

Jia Y, Ye L, Ji K, Toms AM, Davies ML, Ruge F, Ji J, Hargest R, Jiang WG.

Oncol Rep. 2014 Jan;31(1):175-82. doi: 10.3892/or.2013.2866. Epub 2013 Nov 20.

PMID:
24270644
6.

Patrinia scabiosaefolia induces mitochondrial-dependent apoptosis in a mouse model of colorectal cancer.

Liu L, Shen A, Chen Y, Wei L, Lin J, Sferra TJ, Hong Z, Peng J.

Oncol Rep. 2013 Aug;30(2):897-903. doi: 10.3892/or.2013.2528. Epub 2013 Jun 7.

PMID:
23754194
7.

Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.

Rychahou PG, Jackson LN, Silva SR, Rajaraman S, Evers BM.

Ann Surg. 2006 Jun;243(6):833-42; discussion 843-4.

8.

Phenylarsine oxide induces apoptosis in Bax- and Bak-deficient cells through upregulation of Bim.

Ni B, Ma Q, Li B, Zhao L, Liu Y, Zhu Y, Chen Q.

Clin Cancer Res. 2012 Jan 1;18(1):140-51. doi: 10.1158/1078-0432.CCR-10-3450. Epub 2011 Nov 2.

10.

Effects of ellagic acid on chemosensitivity to 5-fluorouracil in colorectal carcinoma cells.

Kao TY, Chung YC, Hou YC, Tsai YW, Chen CH, Chang HP, Chou JL, Hsu CP.

Anticancer Res. 2012 Oct;32(10):4413-8.

PMID:
23060566
11.

Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer.

Manoochehri M, Karbasi A, Bandehpour M, Kazemi B.

Pathol Oncol Res. 2014 Apr;20(2):301-7. doi: 10.1007/s12253-013-9695-0. Epub 2013 Oct 14.

PMID:
24122668
12.
13.

Oncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cells.

Selimoglu-Buet D, Gallais I, Denis N, Guillouf C, Moreau-Gachelin F.

PLoS One. 2012;7(11):e49052. doi: 10.1371/journal.pone.0049052. Epub 2012 Nov 7.

14.

Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.

Yuen HF, Chan KK, Grills C, Murray JT, Platt-Higgins A, Eldin OS, O'Byrne K, Janne P, Fennell DA, Johnston PG, Rudland PS, El-Tanani M.

Clin Cancer Res. 2012 Jan 15;18(2):380-91. doi: 10.1158/1078-0432.CCR-11-2035. Epub 2011 Nov 16.

15.
16.

Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study.

Sasaki K, Tsuno NH, Sunami E, Kawai K, Hongo K, Hiyoshi M, Kaneko M, Murono K, Tada N, Nirei T, Takahashi K, Kitayama J.

Anticancer Drugs. 2012 Aug;23(7):675-82. doi: 10.1097/CAD.0b013e328353f8c7.

PMID:
22561420
17.

GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.

Wang Z, Jiang B, Chen L, Di J, Cui M, Liu M, Ma Y, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Dong B, Ji J, Su X.

J Transl Med. 2014 Jan 21;12:15. doi: 10.1186/1479-5876-12-15.

18.

The synergistic effect of 5-aza-2'-deoxycytidine and 5-fluorouracil on drug-resistant tumors.

Morita S, Iida S, Kato K, Takagi Y, Uetake H, Sugihara K.

Oncology. 2006;71(5-6):437-45. Epub 2007 Aug 9.

PMID:
17690560
19.

Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.

Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC.

Carcinogenesis. 2013 Jun;34(6):1331-42. doi: 10.1093/carcin/bgt060. Epub 2013 Feb 7.

20.
Items per page

Supplemental Content

Write to the Help Desk